Independent news has never been so important.

Did you know that you can get Democracy Now! delivered to your inbox every day? Sign up for our Daily News Digest today! Don't worry, we'll never share or sell your information.

FDA Wants Reformulated Vaccines to Combat New Coronavirus Lineages

HeadlineJul 05, 2022

The Food and Drug Administration says it will not require large-scale clinical trials for new formulations of COVID-19 boosters. The FDA made the announcement as a panel of experts said drugmakers should prepare vaccine boosters for the fall that are tailored to combat Omicron variant sublineages that are currently dominant in the United States. Nationwide, about 17% of coronavirus tests are coming back positive — the highest test positivity rate since a massive surge of COVID-19 cases last winter.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation